From Aortitis to Sweet’s: The Immune Spectrum of G-CSF Adverse Events

Key Points

• G-CSF is associated with a wide range of adverse events, particularly affecting immune responses.
• Among the identified adverse events, aortitis and Sweet's syndrome are significant manifestations.
• Analysis of clinical cases shows diverse inflammatory pathways linked to G-CSF administration in affected patients.
• Understanding these immune responses may enhance clinical management and monitoring strategies for G-CSF therapy.